CDMO platform expansion is gaining momentum at Piramal Pharma as the company takes majority control of Yapan Bio, the transaction turns Yapan Bio into a subsidiary and strengthens Piramal Pharma’s capabilities in vaccine and biologics development
FDA observation outcomes at Aurobindo Pharma's Raleigh facility have moved into a new phase after the US regulator classified the site as Voluntary Action Indicated
Chandipura Virus cases have surged in Gujarat, with the death toll reaching 27. The state has reported 41 confirmed infections so far. The outbreak has raised concern due to the virus's rapid progression. Chandipura virus cases have mainly been...
In an interaction with Thiruamuthan, Assistant Editor at India Pharma Outlook, Rashida Najmi, Chief Quality Officer, Piramal Pharma Limited, discusses the evolving quality and regulatory priorities shaping global pharmaceutical operations, with a foc
Drug quality has become a bigger regulatory priority in India as authorities intensify inspections to strengthen manufacturing standards
Ebola outbreak developments in the Democratic Republic of Congo have taken another serious turn, with confirmed cases rising to 4,449 and deaths reaching 2,061
The Ebola death toll in the Democratic Republic of Congo has crossed 2,000 as the country battles a rapidly spreading outbreak. The outbreak has already claimed 2,011 confirmed deaths across five provinces.
Biosafety testing is becoming increasingly important as biopharmaceutical companies develop complex biologics and advanced therapies across Asia-Pacific
Cancer care continues to evolve rapidly as global and Indian pharmaceutical companies intensify efforts across drug development, partnerships, and access programs.
Global health concern intensifies as the latest Salmonella outbreak in the United States exposes the growing risks linked to foodborne infections
.jpg)
, CDSCO.jpg)